stoxline Quote Chart Rank Option Currency Glossary
Evolus, Inc. (EOLS)
11.53  -0.03 (-0.26%)    04-19 16:00
Open: 11.47
High: 11.61
Volume: 337,381
Pre. Close: 11.56
Low: 11.36
Market Cap: 709(M)
Technical analysis
2024-04-19 5:09:10 PM
Short term     
Mid term     
Targets 6-month :  15.39 1-year :  16.78
Resists First :  13.18 Second :  14.36
Pivot price 12.7
Supports First :  11.26 Second :  9.36
MAs MA(5) :  11.73 MA(20) :  13
MA(100) :  12.19 MA(250) :  10.11
MACD MACD :  -0.6 Signal :  -0.4
%K %D K(14,3) :  6.6 D(3) :  6.4
RSI RSI(14): 21.3
52-week High :  15.43 Low :  7.07
Price, MAs and Bollinger Bands

Price has closed below its short-term moving average. Short-term moving average is currently below mid-term; and below long-term moving average. From the relationship between price and moving averages: This stock is BEARISH in short-term; and NEUTRAL in mid-long term.
[ EOLS ] has closed above bottom band by 13.6%. Bollinger Bands are 87.3% wider than normal. The large width of the bands suggest high volatility as compared to its normal range. The bands have been in this wide range for 4 days. This is a sign that the current trend might continue.

Stock Price Prediction
If tomorrow: Open lower Open higher
High: 11.62 - 11.72 11.72 - 11.78
Low: 11.16 - 11.27 11.27 - 11.34
Close: 11.39 - 11.56 11.56 - 11.66
Company Description

Evolus, Inc., a performance beauty company, provides medical aesthetic products for physicians and their patients in the United States. It offers Jeuveau, a proprietary 900 kilodalton purified botulinum toxin type A formulation for the temporary improvement in the appearance of moderate to severe glabellar lines in adults. The company was incorporated in 2012 and is headquartered in Newport Beach, California.

Headline News

Fri, 19 Apr 2024
Why Evolus (EOLS) Might Surprise This Earnings Season - Yahoo Movies Canada

Thu, 18 Apr 2024
When Will Evolus, Inc. (NASDAQ:EOLS) Become Profitable? - Simply Wall St

Tue, 16 Apr 2024
Evolus, Inc. (NASDAQ:EOLS) Short Interest Down 6.6% in March - MarketBeat

Thu, 11 Apr 2024
Evolus (NASDAQ:EOLS) Given “Buy” Rating at Needham & Company LLC - Defense World

Sat, 06 Apr 2024
SG Americas Securities LLC Has $463000 Stake in Evolus, Inc. (NASDAQ:EOLS) - Defense World

Sat, 06 Apr 2024
Evolus, Inc. (NASDAQ:EOLS) is favoured by institutional owners who hold 57% of the company - Yahoo Finance

Financial Analysis
Price to Book Value:
P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly.
Price to Earnings:
PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS).
Discounted cash flow:
DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows.
Return on Assets:
ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit.
Return on Equity:
ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency.
Debt to Equity:
evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn.
Stock Basics & Statistics
Drug Manufacturers - Specialty & Generic
Shares Out 62 (M)
Shares Float 39 (M)
Held by Insiders 13 (%)
Held by Institutions 77.1 (%)
Shares Short 4,650 (K)
Shares Short P.Month 4,960 (K)
Stock Financials
EPS -1.09
EPS Est Next Qtrly 0
EPS Est This Year 0
EPS Est Next Year 0
Book Value (p.s.) -0.37
Profit Margin -30.6 %
Operating Margin -8.4 %
Return on Assets (ttm) -12.4 %
Return on Equity (ttm) 0 %
Qtrly Rev. Growth 39.7 %
Gross Profit (p.s.) 0
Sales Per Share 3.28
EBITDA (p.s.) -0.51
Qtrly Earnings Growth 0 %
Operating Cash Flow -34 (M)
Levered Free Cash Flow -10 (M)
Stock Valuations
PE Ratio -10.68
PEG Ratio -2.3
Price to Book value -32.03
Price to Sales 3.5
Price to Cash Flow -20.85
Stock Dividends
Dividend 0
Forward Dividend 0
Dividend Yield 0%
Dividend Pay Date Invalid DateTime.
Ex-Dividend Date Invalid DateTime.

StockChart iOS

StoxlineLite iOS

StoxlineLite iOS

OptionCalc iOS

StockChart Android

StoxlineLite Android

StoxlinePro Android

OptionCalc Android